openPR Logo
Press release

Acute Heart Failure (AHF) Therapeutics Market to Make Huge Impact in near Future: Basic Influencing Factors Driving the Industry 2018-2026

01-15-2019 10:06 AM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Acute Heart Failure (AHF) Therapeutics Market

Acute Heart Failure (AHF) Therapeutics Market

Acute heart failure (AHF) is a progressive condition, in which, the heart muscle is unable to pump enough blood through the heart to meet body’ optimal blood and oxygen level. Congestive heart failure is type of heart failure which requires timely medical attention. Moreover, distinguish between acute and chronic heart failure is important from a clinical standpoint, on which further medication depends. For this, N terminal proB-type natriuretic peptide levels are used for distinguishing acute versus chronic left ventricular dysfunction. An elevated levels of natriuretic peptide were present in patients with acute heart failure compared to those with chronic heart failure patient.

Download PDF Brochure Of This Research Report @

Heart failure symptoms vary widely from person to person, depending on types of heart failure patient. The main symptoms of heart failure are caused due to fluid accumulation or congestion and poor blood flow to the body. Symptoms caused by fluid accumulation or congestion includes shortness of breath, weight gain, coughing, swollen ankles, legs or abdomen, while dizziness, rapid heart rate, and fatigue are symptoms associated with reduced blood flow to parts of the body.

Acute Heart Failure (AHF) Therapeutics Market Drivers:

The global acute heart failure therapeutics market is expected to witness significant growth due to approval of new drugs. For instance, in July 2015, Novartis received U.S. Food and Drug Administration (FDA) approval for their Entresto(TM) (sacubitril/valsartan) tablets on the treatment of heart failure with reduced ejection fraction. Entresto is indicated to reduce the risk of cardiovascular death and heart failure hospitalization.

Furthermore, robust pipeline of drugs over the forecast period (2018-2026), is another factor driving growth of acute heart failure therapeutics market. For instance, in March 2017, Cardioxyl Pharmaceuticals’ CXL-1427: a novel nitroxyl (HNO) donor (prodrug), which now operates under the Bristol-Myers Squibb Company (after Cardioxyl Pharmaceuticals’ acquisition by Bristol-Myers Squibb in December 2015); is present in Phase 2 clinical development phase. CXL-1427 is indicated to use as an intravenous treatment for acute decompensated heart failure (ADHF). Successful completion and further launch of Bristol-Myers Squibb’s innovative drug in future, will help to boost the acute heart failure (AHF) therapeutics market growth during the forecast period.

Acute Heart Failure (AHF) Therapeutics Market – Regional Analysis:

Geographically, the market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America is expected to hold dominant position in global acute heart failure (AHF) therapeutics market, due to high prevalence of acute heart failure cases, in this region. For instance, according to Centers for Disease Control and Prevention (CDC), June 2016, around 5.7 million adults in the U.S. suffered from heart failure, in 2016. Moreover, about half of the people who develop heart failure die within 5 years of diagnosis.

Growing prevalence of obesity have increased risk of developing acute heart failure (AHF). According to CDC, May 2017 data findings, between 2013 and 2014, 37.9% of adults aged 20 years and over were obese, in the U.S. Therefore, high prevalence of risk factors and acute heart failure (AHF) cases in these region are expected to drive growth of this market over the forecast period.

Acute Heart Failure (AHF) Therapeutics Market – Competitive Landscape:

Some of the key players in this market are
• Novartis AG,
• Cardiorentis AG,
• Bristol-Myers Squibb Company,
• Amgen Inc.,
• Bayer AG,
• Cytokinetics Inc.,
• Merck & Company Inc.,
• Ono Pharmaceutical Co., Ltd.,
• Pfizer Inc.,

Key players in the marker are engaged in development of new drugs for acute heart failure (AHF). These players are incorporating collaboration strategies to remain competitive in the market.

Request For Customization @

Acute Heart Failure (AHF) Therapeutics Market Taxonomy:

By Disorder Type:

• Right-sided Heart Failure
• Left-sided Heart Failure
◦ Systolic Failure
◦ Diastolic Failure
• Congestive Heart Failure

By Drug Category:

• Angiotensin-Converting Enzyme (ACE) Inhibitors
◦ Captopril (Capoten)
◦ Enalapril (Vasotec)
◦ Fosinopril (Monopril)
◦ Lisinopril (Prinivil, Zestril)
◦ Perindopril (Aceon)
◦ Quinapril (Accupril)
◦ Ramipril (Altace)
◦ Others

• Angiotensin II Receptor Blockers
◦ Candesartan (Atacand)
◦ Losartan (Cozaar)
◦ Valsartan (Diovan)

Aldosterone Antagonists:
• Spironolactone (Aldactone)
• Eplerenone (Inspra)
• Diuretics
• Furosemide (Lasix)
• Bumetanide (Bumex)
• Torsemide (Demadex)
• Chlorothiazide (Diuril)

By Region:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute Heart Failure (AHF) Therapeutics Market to Make Huge Impact in near Future: Basic Influencing Factors Driving the Industry 2018-2026 here

News-ID: 1498036 • Views: 279

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases

More Releases for AHF

Acute Heart failure (AHF) Market Insight, Epidemiology and Market Forecast - 202 …
Acute Heart failure (AHF) Market research report is the new statistical data source added by Infinity Business Insights. When your heart can't pump enough blood to keep up with your body's demands, you have heart failure. This can be chronic, which means that it develops over time. It can also be acute, which means it occurs suddenly. According to a 2014 research, there were roughly 26 million people living with
Anhydrous Hydrogen Fluoride (AHF) Market: Competitive Dynamics & Global Outlook …
LP INFORMATION recently released a research report on the Anhydrous Hydrogen Fluoride (AHF) market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Anhydrous Hydrogen Fluoride (AHF) market by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of Anhydrous Hydrogen Fluoride (AHF) market, market
Anhydrous Hydrogen Fluoride (AHF) Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Anhydrous Hydrogen Fluoride (AHF) Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Anhydrous Hydrogen Fluoride (AHF) market will register a 5.0% CAGR in terms of revenue, the global market size will reach US$ 3016.7 million by 2024, from US$ 2483.8 million
Acute Heart failure (AHF) Market Forecast, Size, strategize, Forecast 2028
Acute Heart Failure “Acute Heart Failure-Epidemiology Forecasting Intelligence” report provides a comprehensive analysis of the Acute Heart Failure epidemiology, providing the historical, current, and forecasted data for the United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan during the period from 2018-2028. Our epidemiology services include: • Incidence and prevalence • Diagnosis rate, treatment rate and mortality patterns • Epidemiology-based forecasting and disease trends • Size of different patient segments
Anhydrous Hydrogen Fluoride (AHF) Market Research and Chemical Analysis 2019 to …
Global Anhydrous Hydrogen Fluoride (AHF) Market Insights, Forecast To 2025 studies the latest industry trends, market development aspects, market gains, and industry scenario during the forecast period. The report provides the details related to fundamental overview, development status, latest advancements, market dominance and market dynamics. Global Anhydrous Hydrogen Fluoride (AHF) market size will increase to 5240 Million US$ by 2025, from 2630 Million US$ in 2018, at a CAGR of 9.0%
Anhydrous Hydrogen Fluoride (AHF) Market Definitions, Research(Strengths,Weaknes …
Qyresearchreports include new market research report Global Anhydrous Hydrogen Fluoride (AHF) Market Research Report 2018 to its huge collection of research reports. This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Anhydrous Hydrogen Fluoride (AHF) industry. This report splits Anhydrous Hydrogen Fluoride (AHF)